Integra LifeSciences, Johnson & Johnson agree on $1.045 billion division sale
MLex Summary: Johnson & Johnson has agreed to sell its Codman Neurosurgery business for $1.045 billion to Integra LifeSciences Holdings, according to a statement from Integra. The deal will boost the...To view the full article, register now.
Already a subscriber? Click here to view full article